Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
DABIGATRAN ETEXILATO CINFA 110 MG CAPSULAS DURAS EFG
Capsule
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- DABIGATRAN ETEXILATO MESILATO — 110 mg
- Pharmaceutical form Home Med Cabinet grouping
- Capsule
- Availability in Spain
- All 3 packs marketed
Packs
DABIGATRAN ETEXILATO CINFA 110 MG CAPSULAS DURAS EFG, 10 cápsulas
10 pcs
National code
Marketed762332Strength of this pack 110 mg
DABIGATRAN ETEXILATO CINFA 110 MG CAPSULAS DURAS EFG, 30 cápsulas
30 pcs
National code
Marketed762333Strength of this pack 110 mg
DABIGATRAN ETEXILATO CINFA 110 MG CAPSULAS DURAS EFG, 60 cápsulas
60 pcs
National code
Marketed762334Strength of this pack 110 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 88692Official data
- Marketing authorisation holder
- LABORATORIOS CINFA S.A.Official data
- Authorised
- Mar 1, 2023Official data
- Authority form code
- 32Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.